About Ten63 Therapeutics
Ten63 Therapeutics builds BEYOND, the world's first Large Quantum Chemistry Model — pairing generative chemistry at scale with quantum-accurate simulation (Superlearning) to design therapeutics for previously undruggable and under-drugged targets.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Undisclosed
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
ten63tx.com
Domain Registered Date
Dec 17, 2019
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $15,900,000 · Series-A
fundraisingfox.com
- Milestone
Website domain registered
ten63tx.com
Investors & Backers
IndieBio
Funding History
Series-A
· May 2, 2023
$15,900,000 fundraisingfox.com
Venture Round
· Undisclosed
Undisclosed Source
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026